Skip to main content
. 2023 May 17;55(4):1104–1112. doi: 10.4143/crt.2023.502

Table 2.

Objective responses of the patients who were evaluable following proton therapy

In-field target Out-field target
CR PR SD PD
CR 1 0 1 0
PR 0 6 5 2
SD 0 0 0 1
PD 0 0 0 7

In-field and out-field overall response rates were 30.4% (7/23) and 65.2% (15/23), respectively. CR, complete response; PD, progressive disease; PR, partial response; SD, stable disease.